[scene · viewpoint] he Shengjiang: Pediatrics is in the ascendant, source decision helps new development
Time of Update: 2019-07-18
The development of Chinese children's drug market is slow, and there are many problems such as few varieties, vague dosage and lack of specifications for a long time, which are concerned by both the industry and the state.
In depth analysis: 17 varieties market changes
Time of Update: 2018-10-10
In 2015, Iressa, the first generation of non-small cell lung cancer product under AstraZeneca, passed the first round of drug price negotiation, with a decrease rate of 55%, and has achieved large market volume.
When can children's medicine become the focus again
Time of Update: 2018-04-08
[China Pharmaceutical network industry trends] recently, there are more news about children's drugs, and problems such as drug safety, less special drugs for children, and less
Harm of mint essence
Time of Update: 2017-06-08
Xiaobian said that peppermint essence is also essential in our food industry and daily chemical industry, but we must pay attention to dosage.
Guiding opinions of the general office of the State Council on improving the centralized purchase of drugs in public hospitals
Time of Update: 2015-02-28
Source: People's governments of all provinces, autonomous regions and municipalities directly under the central government (GBF  No
7) on February 28, 2015, all
Experts call for specialization of children's drug approval
Time of Update: 2013-06-05
2013-06-05 source: the press conference of "three dolls · Aizi prescription children's drug safety white paper" sponsored by China care for the next generation working committee
Frequent occurrence of adverse events in children
Time of Update: 2013-05-31
2013-05-31 source: the first Financial Daily yesterday, the first domestic children's drug safety report "white paper of 2013 children's drug safety investigation report